Order Article Reprints

Lu Y, Pan W, Deng S, Dou Q, Wang X, An Q, Wang X, Ji H, Hei Y, Chen Y, et al. Redefining the Incidence and Profile of Fluoropyrimidine-Associated Cardiotoxicity in Cancer Patients: A Systematic Review and Meta-Analysis. Pharmaceuticals. 2023; 16(4):510. https://doi.org/10.3390/ph16040510

Lu, Yajie, Wei Pan, Shizhou Deng, Qiongyi Dou, Xiangxu Wang, Qiang An, Xiaowen Wang, Hongchen Ji, Yue Hei, Yan Chen, and et al. 2023. "Redefining the Incidence and Profile of Fluoropyrimidine-Associated Cardiotoxicity in Cancer Patients: A Systematic Review and Meta-Analysis" Pharmaceuticals 16, no. 4: 510. https://doi.org/10.3390/ph16040510

Lu, Y., Pan, W., Deng, S., Dou, Q., Wang, X., An, Q., Wang, X., Ji, H., Hei, Y., Chen, Y., Yang, J., & Zhang, H.-M. (2023). Redefining the Incidence and Profile of Fluoropyrimidine-Associated Cardiotoxicity in Cancer Patients: A Systematic Review and Meta-Analysis. Pharmaceuticals, 16(4), 510. https://doi.org/10.3390/ph16040510